EMA’s human medicines committee (CHMP) has started a rolling review of the vaccine against Covid-19 of the biotechnological pharmaceutical company HIPRA.
The HIPRA’s Covid-19...
EMA has recommended granting a marketing authorisation in the European Union (EU) for Kimmtrak (tebentafusp), a monotherapy for the treatment of adult patients with...
Pfizer Inc. and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive...